Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

“I believe JOURNAVX could redefine the management of pain and become a foundational treatment option for people with all types of moderate-to-severe acute pain, where options aside from opioids ...

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...

Writing in the journal Frontiers in Conservation Science, former Montana bear management specialist ... Administration approved a new pain medicine called Journavx (suzetrigine), made by Vertex ...

Writing in the journal Frontiers in Conservation Science, former Montana bear management specialist ... Administration approved a new pain medicine called Journavx (suzetrigine), made by Vertex ...

RBC Capital notes that the clinical review documents associated with Sector Perform-rated Vertex Pharmaceuticals (VRTX)’ recent approval of ...

Sensory neurons that respond to temperature, touch and pain have ways of adapting to repeated stimuli that can change how a ...

A multistate pain management company made millions of dollars off unneeded injections into patients, turning them into 'human ...